In this issue of Clinics in Laboratory Medicine, guest editors Drs. Christopher P. Holstege and Joshua D. King bring their considerable expertise to the topic of COVID-19 Molecular Testing and Clinical Correlates. Top experts in the field cover key topics such as point-of-care molecular assays for SARS-CoV-2; strategies for scaling up SARS-CoV-2 molecular testing capacity; cycle threshold values from SARS-CoV-2 PCR assays; and more.
Analytic and Clinical Performance of Major Commercial Severe Acute Respiratory Syndrome Coronavirus 2 Molecular Assays in the United States The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States An Overview of SARS-CoV-2 Molecular Diagnostics in Europe SARS-CoV-2 Molecular Diagnostics in China Rapid Antigen Assays for SARS-CoV-2: Promise and Peril Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2 Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Assays: Interpretation and Potential Use Cases Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-2 Strategies for Scaling up SARS-CoV-2 Molecular Testing Capacity Approaches to Deployment of Molecular Testing for SARS-CoV-2 in Resource-Limited Settings Novel Assays for Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.